Used in the synthesis of pharmaceutical intermediates, particularly in the development of cardiovascular drugs. Its structure serves as a key scaffold in creating biologically active molecules due to its similarity to purine bases, enabling interactions with biological receptors and enzymes. Commonly employed in research for novel antiplatelet and anticoagulant agents. Also explored in the design of kinase inhibitors for potential anticancer therapies. Its heterocyclic framework enhances metabolic stability and bioavailability in drug candidates.